AMGN 8-K 2026-10-27

AMGEN INC (AMGN) 8-K dated 2026-10-27 — accession 0000318154-26-000144. This URL is the filing, not the AMGN hub.

AMGEN INC (AMGN) is a drug manufacturers - general company listed on US.

AMGEN INC filed a 8-K on 2026-10-27. Accession 0000318154-26-000144.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B.

Not investment advice. The AMGN SEC hub lists recent forms. The stock page is the research view.